Cognitive Function and All-Cause Mortality in Maintenance Hemodialysis Patients

被引:103
|
作者
Drew, David A. [1 ]
Weiner, Daniel E. [1 ]
Tighiouart, Hocine [2 ,3 ]
Scott, Tammy [4 ]
Lou, Kristina [1 ]
Kantor, Amy [1 ]
Fan, Li [1 ]
Strom, James A. [5 ]
Singh, Ajay K. [6 ]
Sarnak, Mark J. [1 ]
机构
[1] Tufts Med Ctr, Dept Med, Div Nephrol, Boston, MA 02111 USA
[2] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[3] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA
[4] Tufts Med Ctr, Dept Psychiat, Boston, MA 02111 USA
[5] St Elizabeths Med Ctr, Boston, MA USA
[6] Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Cognition; cognitive impairment; executive function; memory; neurocognitive testing; cardiovascular disease; mortality; hemodialysis; end-stage renal disease (ESRD); DIALYSIS PATIENTS; ELDERLY PEOPLE; IMPAIRMENT; DEMENTIA; PERFORMANCE; DISEASE; OUTCOMES; COHORT;
D O I
10.1053/j.ajkd.2014.07.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Cognitive impairment is common in hemodialysis patients and is associated with significant morbidity. Limited information exists about whether cognitive impairment is associated with survival and whether the type of cognitive impairment is important. Study Design: Longitudinal cohort. Setting & Participants: Cognitive function was assessed at baseline and yearly using a comprehensive battery of cognitive tests in 292 prevalent hemodialysis patients. Predictor: Using principal component analysis, individual test results were reduced into 2 domain scores, representing memory and executive function. By definition, each score carried a mean of 0 and SD of 1. Outcomes: Association of each score with all-cause mortality was assessed using Cox proportional hazards models adjusted for demographics and dialysis and cardiovascular (CV) risk factors. Results: Mean age of participants was 63 years, 53% were men, 23% were African American, and 90% had at least a high school education. During a median follow-up of 2.1 (IQR, 1.1-3.7) years, 145 deaths occurred. Each 1-SD better executive function score was associated with a 35% lower hazard of mortality (HR, 0.65; 95% CI, 0.55-0.76). In models adjusting for demographics and dialysis-related factors, this relationship was partially attenuated but remained significant (HR, 0.81; 95% CI, 0.67-0.98), whereas adjustment for CV disease and heart failure resulted in further attenuation (HR, 0.87; 95% CI, 0.72-1.06). Use of time-dependent models showed a similar unadjusted association (HR, 0.62; 95% CI, 0.54-0.72), with the relationship remaining significant after adjustment for demographics and dialysis and CV risk factors (HR, 0.79; 95% CI, 0.66-0.94). Better memory was associated with lower mortality in univariate analysis (HR per 1 SD, 0.82; 95% CI, 0.690.96), but not when adjusting for demographics (HR, 1.00; 95% CI, 0.83-1.19). Limitations: Patients with dementia were excluded from the full battery, perhaps underestimating the strength of the association. Conclusions: Worse executive function and memory are associated with increased risk of mortality. For memory, this association is explained by patient demographics, whereas for executive function, this relationship may be explained in part by CV disease burden. (C) 2015 by the National Kidney Foundation, Inc.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 50 条
  • [41] Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients
    Inoue, Tomoko
    Okano, Kazuhiro
    Tsuruta, Yuki
    Tsuruta, Yukio
    Tsuchiya, Ken
    Akiba, Takashi
    Nitta, Kosaku
    [J]. INTERNAL MEDICINE, 2015, 54 (24) : 3133 - 3137
  • [42] Docosahexaenoic Acid Is an Independent Predictor of All-Cause Mortality in Hemodialysis Patients
    Hamazaki, Kei
    Terashima, Yoshihiro
    Itomura, Miho
    Sawazaki, Shigeki
    Inagaki, Hitoshi
    Kuroda, Masahiro
    Tomita, Shin
    Hirata, Hitoshi
    Inadera, Hidekuni
    Hamazaki, Tomohito
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (02) : 105 - 110
  • [43] Association of serum adiponectin levels with all-cause mortality in hemodialysis patients
    Ohashi, Naro
    Kato, Akihiko
    Misaki, Taro
    Sakakima, Masanori
    Fujigaki, Yoshihide
    Yamamoto, Tatsuo
    Hishida, Akira
    [J]. INTERNAL MEDICINE, 2008, 47 (06) : 485 - 491
  • [44] Endocan as a Potential Marker for Predicting All-Cause Mortality in Hemodialysis Patients
    Lin, Jia-Hong
    Hsu, Bang-Gee
    Wang, Chih-Hsien
    Tsai, Jen-Pi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [45] Weight loss increases all-cause mortality in a cohort of hemodialysis patients
    De Mutsert, R.
    Vandenbroucke, J. P.
    Boeschoten, E. W.
    Krediet, R. T.
    Dekker, F. W.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 61 - 62
  • [46] Plasma Cystine Levels and Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Suzuki, Shota
    Shino, Midori
    Fujikawa, Tetsuya
    Itoh, Yoko
    Ueda, Eiko
    Hashimoto, Tatsuo
    Kuji, Tadashi
    Kobayashi, Naoyuki
    Ohnishi, Toshimasa
    Hirawa, Nobuhito
    Tamura, Kouichi
    Toya, Yoshiyuki
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (05) : 476 - 484
  • [47] Association of serum globulin with all-cause mortality in incident hemodialysis patients
    Pai, Alex Y.
    Sy, John
    Kim, Joseph
    Kleine, Carola-Ellen
    Edward, Jessica
    Hsiung, Jui-Ting
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1993 - 2003
  • [48] All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
    Sattar, Abdus
    Argyropoulos, Christos
    Weissfeld, Lisa
    Younas, Nizar
    Fried, Linda
    Kellum, John A.
    Unruh, Mark
    [J]. BMC NEPHROLOGY, 2012, 13
  • [49] Racial disparities in the effect of low cognitive function on all-cause mortality
    Banerjee, Sri
    Szirony, Gary
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [50] All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
    Abdus Sattar
    Christos Argyropoulos
    Lisa Weissfeld
    Nizar Younas
    Linda Fried
    John A Kellum
    Mark Unruh
    [J]. BMC Nephrology, 13